Stelios-Elion Bousi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stelios-Elion Bousi has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
Marinos Zachiotis
Alfa Institute of Biomedical Sciences, Athens, Greece
3 shared publicationsMassimo Malago
Organ Transplant Center of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
2 shared publicationsAbhideep Chaudhary
1 shared publicationAbhinav Humar
1 shared publicationAbraham Shaked
1 shared publicationAlbert Chan
1 shared publication
Latest Publications
- 27 October 2025
- Published by Wolters Kluwer Health in Transplantation
- Vol. 110 (1) , e197-e203
Global Outcomes of Open Versus Laparoscopic Versus Robotic Donor Hepatectomy: A Prospective Study From the International LDLT Registry (LDLTregistry.org)
Background.: Living donor liver transplantation is a critical solution to the global organ shortage. Comparisons of donor short-term outcomes according to the surgical approach are limited to a few single-center retrospective studies. This study aimed to evaluate the short-term outcomes of open, laparoscopic, and robotic surgical approaches to living donor hepatectomy using data from the prospective International Living Donor Liver Transplantation Registry (LDLTregistry.org). Methods.: Data from 2600 living donors undergoing hepatectomy were prospectively collected from September 2023 to February 2025. Donors were grouped into open (1726; 66.4%), laparoscopic (242; 9.3%), and robotic (632; 24.3%) approaches. Results.: The mean donor age was 33 (SD 9.4) y, with 45% women and a mean body mass index of 24.7 kg/m² (SD 6.5). Conversion rates were 15.3% for laparoscopic and 5.1% for robotic approaches (odds ratio, 0.30; 95% confidence interval, 0.17-0.50; P < 0.001). Robotic hepatectomy was associated with the lowest intraoperative blood loss (70 mL; interquartile range, 50–100), lowest pain scores on postoperative day 1 (visual analog scale, 2.3; SD 1.9), and shortest hospital stay (4 d; interquartile range, 3–5). Robotic hepatectomy was associated with the lowest overall (grade ≥1; 4.6%) and major (grade ≥3a; 0.3%) complication rates compared with laparoscopic (16.5% overall, 3.7% major) and open (10.4% overall, 1.9% major) approaches ( P < 0.001). Conclusions.: This is the first global study to show evidence that robotic living donor hepatectomy offers superior short-term outcomes compared with laparoscopic and open approaches. Although open surgery remains the most common approach, robotic techniques show promise for improving donor safety and recovery.
- 27 October 2025
- Published by Wolters Kluwer Health in Transplantation
- Vol. 110 (1) , e197-e203
Global Outcomes of Open Versus Laparoscopic Versus Robotic Donor Hepatectomy: A Prospective Study From the International LDLT Registry (LDLTregistry.org)
Background.: Living donor liver transplantation is a critical solution to the global organ shortage. Comparisons of donor short-term outcomes according to the surgical approach are limited to a few single-center retrospective studies. This study aimed to evaluate the short-term outcomes of open, laparoscopic, and robotic surgical approaches to living donor hepatectomy using data from the prospective International Living Donor Liver Transplantation Registry (LDLTregistry.org). Methods.: Data from 2600 living donors undergoing hepatectomy were prospectively collected from September 2023 to February 2025. Donors were grouped into open (1726; 66.4%), laparoscopic (242; 9.3%), and robotic (632; 24.3%) approaches. Results.: The mean donor age was 33 (SD 9.4) y, with 45% women and a mean body mass index of 24.7 kg/m² (SD 6.5). Conversion rates were 15.3% for laparoscopic and 5.1% for robotic approaches (odds ratio, 0.30; 95% confidence interval, 0.17-0.50; P < 0.001). Robotic hepatectomy was associated with the lowest intraoperative blood loss (70 mL; interquartile range, 50–100), lowest pain scores on postoperative day 1 (visual analog scale, 2.3; SD 1.9), and shortest hospital stay (4 d; interquartile range, 3–5). Robotic hepatectomy was associated with the lowest overall (grade ≥1; 4.6%) and major (grade ≥3a; 0.3%) complication rates compared with laparoscopic (16.5% overall, 3.7% major) and open (10.4% overall, 1.9% major) approaches ( P < 0.001). Conclusions.: This is the first global study to show evidence that robotic living donor hepatectomy offers superior short-term outcomes compared with laparoscopic and open approaches. Although open surgery remains the most common approach, robotic techniques show promise for improving donor safety and recovery.
- 7 August 2025
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 142, 106448
Venous thromboembolism associated with infections: a systematic review and meta-analysis
- 7 August 2025
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 142, 106448
Venous thromboembolism associated with infections: a systematic review and meta-analysis
- Open Access
- 5 February 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (4) , 2766-2772
International consensus recommendations for the RAPID procedure in liver transplantation
Introduction: Since its beginning in 1963, liver transplantation has significantly advanced, now including transplant oncology. As indications broaden, donor supply reduces. The two-stage RAPID procedure (initially abbreviated as “Resection And Partial Liver Segment 2/3 Transplantation With Delayed Total Hepatectomy”) has emerged to address the use of small-for-size grafts. However, a comprehensive evaluation of RAPID is essential given its novelty, scarcity, and diverse outcomes reported. Methods: The RAPID Consensus International Society of Liver Surgeons 2023 Zurich initiative established evidence around the RAPID procedure using the Danish Model of Consensus. Engaging an international community of specialists, the initiative ensured multidisciplinary involvement and used the GRADE framework to evaluate the quality of evidence and grade the recommendations. Results: Comprehensive discussions and debates led to internationally recognized recommendations addressing perioperative measures for RAPID. Key recommendations highlighted the significance of standardized nomenclature, specific indications, graft criteria, surgical techniques, optimal interstage timings, and measures to manage potential complications. Conclusion: The consensus provides recommendations for the RAPID procedure, emphasizing transparency and outcome reporting. Establishing dedicated registries can improve care standards, which may ensure the benefits of RAPID by maximizing patient safety and improving outcomes.
- 5 February 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (4) , 2766-2772
Open AccessInternational consensus recommendations for the RAPID procedure in liver transplantation
Introduction: Since its beginning in 1963, liver transplantation has significantly advanced, now including transplant oncology. As indications broaden, donor supply reduces. The two-stage RAPID procedure (initially abbreviated as “Resection And Partial Liver Segment 2/3 Transplantation With Delayed Total Hepatectomy”) has emerged to address the use of small-for-size grafts. However, a comprehensive evaluation of RAPID is essential given its novelty, scarcity, and diverse outcomes reported. Methods: The RAPID Consensus International Society of Liver Surgeons 2023 Zurich initiative established evidence around the RAPID procedure using the Danish Model of Consensus. Engaging an international community of specialists, the initiative ensured multidisciplinary involvement and used the GRADE framework to evaluate the quality of evidence and grade the recommendations. Results: Comprehensive discussions and debates led to internationally recognized recommendations addressing perioperative measures for RAPID. Key recommendations highlighted the significance of standardized nomenclature, specific indications, graft criteria, surgical techniques, optimal interstage timings, and measures to manage potential complications. Conclusion: The consensus provides recommendations for the RAPID procedure, emphasizing transparency and outcome reporting. Establishing dedicated registries can improve care standards, which may ensure the benefits of RAPID by maximizing patient safety and improving outcomes.
- Open Access
- 22 October 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (21) , 6303
Robotic Versus Laparoscopic Versus Open Surgery for Non-Metastatic Pancreatic Neuroendocrine Tumors (pNETs): A Systematic Review and Network Meta-Analysis
Background: This systematic review, using pairwise and network meta-analyses, aimed to compare the intraoperative, short-term, and long-term postoperative outcomes of minimally invasive surgery (MIS) and open surgery (OS) for the management of pancreatic neuroendocrine tumors (pNETs). Methods: Studies reporting on the effects of robotic, laparoscopic, and open surgery on pNETs published before November 2023 on PubMed, Scopus, and CENTRAL were analyzed. Results: Thirty-two studies with 5379 patients were included in this review, encompassing 2251 patients undergoing MIS (1334 laparoscopic, 508 robotic, and 409 unspecified MIS) and 3128 patients undergoing OS for pNETs management. Pairwise meta-analysis revealed that the MIS group had a significantly shorter length of hospital stay ((a low certainty of evidence), MD of −4.87 (−6.19 to −3.56)); less intraoperative blood loss ((a low certainty of evidence), MD of −108.47 (−177.47 to −39.47)); and decreased tumor recurrence ((a high certainty of evidence), RR of 0.46, 95% CI (0.33 to 0.63)). Subgroup analysis indicated a higher R0 resection rate and prolonged operative time for laparoscopic surgery than for OS. The network meta-analysis ranked the robotic approach as superior in terms of the length of hospital stay, followed by the laparoscopic and OS arms. Furthermore, it favored both MIS approaches over OS in terms of the R0 resection rate. No significant differences were found in severe postoperative complications, postoperative fistula formation, mortality, readmission, reoperation, or conversion rates. Conclusions: This review supports the safety of MIS for the treatment of pNETs. However, the varying certainty of evidence emphasizes the need for higher-quality studies.
- 22 October 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (21) , 6303
Open AccessRobotic Versus Laparoscopic Versus Open Surgery for Non-Metastatic Pancreatic Neuroendocrine Tumors (pNETs): A Systematic Review and Network Meta-Analysis
Background: This systematic review, using pairwise and network meta-analyses, aimed to compare the intraoperative, short-term, and long-term postoperative outcomes of minimally invasive surgery (MIS) and open surgery (OS) for the management of pancreatic neuroendocrine tumors (pNETs). Methods: Studies reporting on the effects of robotic, laparoscopic, and open surgery on pNETs published before November 2023 on PubMed, Scopus, and CENTRAL were analyzed. Results: Thirty-two studies with 5379 patients were included in this review, encompassing 2251 patients undergoing MIS (1334 laparoscopic, 508 robotic, and 409 unspecified MIS) and 3128 patients undergoing OS for pNETs management. Pairwise meta-analysis revealed that the MIS group had a significantly shorter length of hospital stay ((a low certainty of evidence), MD of −4.87 (−6.19 to −3.56)); less intraoperative blood loss ((a low certainty of evidence), MD of −108.47 (−177.47 to −39.47)); and decreased tumor recurrence ((a high certainty of evidence), RR of 0.46, 95% CI (0.33 to 0.63)). Subgroup analysis indicated a higher R0 resection rate and prolonged operative time for laparoscopic surgery than for OS. The network meta-analysis ranked the robotic approach as superior in terms of the length of hospital stay, followed by the laparoscopic and OS arms. Furthermore, it favored both MIS approaches over OS in terms of the R0 resection rate. No significant differences were found in severe postoperative complications, postoperative fistula formation, mortality, readmission, reoperation, or conversion rates. Conclusions: This review supports the safety of MIS for the treatment of pNETs. However, the varying certainty of evidence emphasizes the need for higher-quality studies.
- 26 July 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 280 (5) , 706-712
Revolutionizing Organ Transplantation With Robotic Surgery
Objective: The aim of this study was to evaluate the impact of robotic techniques on organ transplantation outcomes. Background: The evolution of organ transplantation is becoming influenced by the adoption of minimally invasive techniques, transitioning from laparoscopic to robotic methods. Robotic surgery has emerged as a significant advancement, providing superior precision and outcomes compared with traditional approaches. Methods: This perspective includes a systematic review of the literature, original data from a high-volume center, as well as an international survey focusing on perceptions related to robotic versus laparoscopic and open approaches. Results: The systematic review and meta-analysis revealed lower morbidity with robotic donor nephrectomy, recipient kidney transplant and donor hepatectomy. Our center’s experience, with over 3000 minimally invasive transplant procedures (kidney, liver, donor, and recipient), supports the superiority of robotic transplant surgery (RTS). The global survey confirms this shift, revealing a preference for robotic approaches due to their reduced morbidity, despite challenges such as access to the robotic system and cost. Conclusions: This comprehensive overview including a systematic review, original data, and perceptions derived from the international survey demonstrate the superiority of robotic transplant surgery (RTS) across a range of organ transplantations, for both donors and recipients. The future of RTS depends on the efforts of the surgical community in addressing challenges such as economic implications, the need for specialized surgical training for numerous surgeons, as well as wide access to robotic systems worldwide.
- 26 July 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 280 (5) , 706-712
Revolutionizing Organ Transplantation With Robotic Surgery
Objective: The aim of this study was to evaluate the impact of robotic techniques on organ transplantation outcomes. Background: The evolution of organ transplantation is becoming influenced by the adoption of minimally invasive techniques, transitioning from laparoscopic to robotic methods. Robotic surgery has emerged as a significant advancement, providing superior precision and outcomes compared with traditional approaches. Methods: This perspective includes a systematic review of the literature, original data from a high-volume center, as well as an international survey focusing on perceptions related to robotic versus laparoscopic and open approaches. Results: The systematic review and meta-analysis revealed lower morbidity with robotic donor nephrectomy, recipient kidney transplant and donor hepatectomy. Our center’s experience, with over 3000 minimally invasive transplant procedures (kidney, liver, donor, and recipient), supports the superiority of robotic transplant surgery (RTS). The global survey confirms this shift, revealing a preference for robotic approaches due to their reduced morbidity, despite challenges such as access to the robotic system and cost. Conclusions: This comprehensive overview including a systematic review, original data, and perceptions derived from the international survey demonstrate the superiority of robotic transplant surgery (RTS) across a range of organ transplantations, for both donors and recipients. The future of RTS depends on the efforts of the surgical community in addressing challenges such as economic implications, the need for specialized surgical training for numerous surgeons, as well as wide access to robotic systems worldwide.
- Open Access
- 22 December 2023
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 37 (2) , 281-292
Pre-operative ultrasound mapping before arteriovenous fistula formation: an updated systematic review and meta-analysis
Background: Arteriovenous fistula represents the preferred vascular access for patients with kidney failure requiring hemodialysis. Surgeons have traditionally used physical examination to identify the most suitable vessels. This meta-analysis aims to evaluate whether ultrasound mapping should be routinely performed before arteriovenous fistula creation. Methods: Medline, Scopus, Web of Science and CENTRAL were systematically searched from inception to November 1, 2022. Randomized controlled trials and cohort studies comparing routine ultrasound mapping to physical examination in terms of arteriovenous fistula patency were included. Meta-analysis was performed by fitting random-effects models. The study protocol has been prospectively registered in PROSPERO (CRD42023402390). Results: Overall, 18 studies were included, comprising 3655 participants. Routine pre-operative ultrasound mapping was associated with significantly lower rates of primary arteriovenous fistula failure (Risk Ratio-RR: 0.56, 95% confidence intervals-CI: 0.37–0.84, low certainty). A significant outcome was observed by separately pooling randomized controlled trials (RR: 0.37, 95% CI: 0.25–0.54). Routine ultrasound mapping was also associated with significantly higher rates of 1-year primary arteriovenous fistula patency (RR: 1.33, 95% CI: 1.19–1.47, moderate certainty). This effect remained significant in the analysis of randomized controlled trials (RR: 1.26, 95% CI: 1.02–1.56). Conclusions: Implementing routine pre-operative ultrasound mapping of vessels is associated with significantly better outcomes in terms of early arteriovenous fistula failure and primary patency rates at 12 months. Further research should confirm the long-term benefits of routine ultrasound examination and evaluate its cost-effectiveness in different populations. Graphical
- 22 December 2023
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 37 (2) , 281-292
Open AccessPre-operative ultrasound mapping before arteriovenous fistula formation: an updated systematic review and meta-analysis
Background: Arteriovenous fistula represents the preferred vascular access for patients with kidney failure requiring hemodialysis. Surgeons have traditionally used physical examination to identify the most suitable vessels. This meta-analysis aims to evaluate whether ultrasound mapping should be routinely performed before arteriovenous fistula creation. Methods: Medline, Scopus, Web of Science and CENTRAL were systematically searched from inception to November 1, 2022. Randomized controlled trials and cohort studies comparing routine ultrasound mapping to physical examination in terms of arteriovenous fistula patency were included. Meta-analysis was performed by fitting random-effects models. The study protocol has been prospectively registered in PROSPERO (CRD42023402390). Results: Overall, 18 studies were included, comprising 3655 participants. Routine pre-operative ultrasound mapping was associated with significantly lower rates of primary arteriovenous fistula failure (Risk Ratio-RR: 0.56, 95% confidence intervals-CI: 0.37–0.84, low certainty). A significant outcome was observed by separately pooling randomized controlled trials (RR: 0.37, 95% CI: 0.25–0.54). Routine ultrasound mapping was also associated with significantly higher rates of 1-year primary arteriovenous fistula patency (RR: 1.33, 95% CI: 1.19–1.47, moderate certainty). This effect remained significant in the analysis of randomized controlled trials (RR: 1.26, 95% CI: 1.02–1.56). Conclusions: Implementing routine pre-operative ultrasound mapping of vessels is associated with significantly better outcomes in terms of early arteriovenous fistula failure and primary patency rates at 12 months. Further research should confirm the long-term benefits of routine ultrasound examination and evaluate its cost-effectiveness in different populations. Graphical
- 24 June 2023
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 8 (8) , 698-699
Launch of the International Living Donor Liver Transplantation Outcomes Registry
- 24 June 2023
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 8 (8) , 698-699
Launch of the International Living Donor Liver Transplantation Outcomes Registry
- Open Access
- 21 March 2022
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 23 (5) , 1-7
Favorable outcomes of patients with sickle cell disease hospitalized due to COVID‑19: A report of three cases
Sickle cell disease (SCD) is one of the most frequent and severe monogenic disorders, affecting millions of individuals worldwide. SCD represents a fatal hematological illness, characterized by veno‑occlusive events and hemolytic anemia. Hemolytic anemia is caused by abnormal sickle‑shaped erythrocytes, which induce parenchymal destruction and persistent organ damage, resulting in considerable morbidity and mortality. During the coronavirus disease 2019 (COVID‑19) pandemic, patients with SCD were characterized as a ‘high‑risk’ group due to their compromised immune system, caused by functional hyposplenism, as well as systemic vasculopathy. COVID‑19 is characterized by endothelial damage and a procoagulant condition. The present study describes the clinical features, management and outcomes of 3 patients with SCD who were hospitalized due to COVID‑19, who all had favorable outcomes despite the complications.
- 21 March 2022
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 23 (5) , 1-7
Open AccessFavorable outcomes of patients with sickle cell disease hospitalized due to COVID‑19: A report of three cases
Sickle cell disease (SCD) is one of the most frequent and severe monogenic disorders, affecting millions of individuals worldwide. SCD represents a fatal hematological illness, characterized by veno‑occlusive events and hemolytic anemia. Hemolytic anemia is caused by abnormal sickle‑shaped erythrocytes, which induce parenchymal destruction and persistent organ damage, resulting in considerable morbidity and mortality. During the coronavirus disease 2019 (COVID‑19) pandemic, patients with SCD were characterized as a ‘high‑risk’ group due to their compromised immune system, caused by functional hyposplenism, as well as systemic vasculopathy. COVID‑19 is characterized by endothelial damage and a procoagulant condition. The present study describes the clinical features, management and outcomes of 3 patients with SCD who were hospitalized due to COVID‑19, who all had favorable outcomes despite the complications.